0001162044-23-001167.txt : 20231113 0001162044-23-001167.hdr.sgml : 20231113 20231113155255 ACCESSION NUMBER: 0001162044-23-001167 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230929 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 PERIOD START: 20240630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSS AMERICAFIRST QUANTITATIVE FUNDS CENTRAL INDEX KEY: 0001539996 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-22669 FILM NUMBER: 231398304 BUSINESS ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 BUSINESS PHONE: 916-757-6862 MAIL ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAFIRST QUANTITATIVE FUNDS DATE OF NAME CHANGE: 20120119 0001539996 S000036986 DSS AmericaFirst Defensive Growth Fund C000113162 DSS AmericaFirst Defensive Growth Fund Class A DGQAX C000113163 DSS AmericaFirst Defensive Growth Fund Class U DGQUX C000113164 DSS AmericaFirst Defensive Growth Fund Class I DGQIX NPORT-P 1 primary_doc.xml NPORT-P false 0001539996 XXXXXXXX S000036986 C000113162 C000113163 C000113164 DSS AMERICAFIRST QUANTITATIVE FUNDS 811-22669 0001539996 549300KFIJ1ZWDPJB360 9700 Village Center Drive Suite 50-N Granite Bay 95746 916-787-9940 AmericaFirst Defensive Growth Fund S000036986 549300S3G3X5IG45FY40 2024-06-30 2023-09-29 N 1053641.19 10762.04 1042879.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 N Abbott Laboratories HQD377W2YR662HK5JX27 Abbott Laboratories 002824100 499.00 NS USD 48328.15 4.63 Long EC CORP US N 1 N N N Archer-Daniels-Midland Co. 549300LO13MQ9HYSTR83 Archer-Daniels-Midland Co. 039483102 633.00 NS USD 47740.86 4.58 Long EC CORP US N 1 N N N Biogen, Inc. W8J5WZB5IY3K0NDQT671 Biogen, Inc. 09062X103 185.00 NS USD 47546.85 4.56 Long EC CORP US N 1 N N N Costco Wholesale Corporation 29DX7H14B9S6O3FD6V18 Costco Wholesale Corporation 22160K105 50.00 NS USD 28248.00 2.71 Long EC CORP US N 1 N N N Eli Lilly & Co. FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co. 532457108 159.00 NS USD 85403.67 8.19 Long EC CORP US N 1 N N N Money Market Obligations Trust N/A Federated Prime Obligations 60934N203 71746.82 NS USD 71746.82 6.88 Long STIV RF US N 1 N N N General Mills, Inc. 2TGYMUGI08PO8X8L6150 General Mills, Inc. 370334104 641.00 NS USD 41017.59 3.93 Long EC CORP US N 1 N N N Gilead Sciences, Inc. 549300WTZWR07K8MNV44 Gilead Sciences, Inc. 375558103 630.00 NS USD 47212.20 4.53 Long EC CORP US N 1 N N N Johnson & Johnson 549300G0CFPGEF6X2043 Johnson & Johnson 478160104 329.00 NS USD 51241.75 4.91 Long EC CORP US N 1 N N N McKesson Corp. 549300WZWOM80UCFSF54 McKesson Corp. 58155Q103 145.00 NS USD 63053.25 6.05 Long EC CORP US N 1 N N N Medtronic PLC 549300GX3ZBSQWUXY261 Medtronic PLC G5960L103 570.00 NS USD 44665.20 4.28 Long EC CORP IE N 1 N N N Mondelez International, Inc. 549300DV9GIB88LZ5P30 Mondelez International, Inc. Class A 609207105 782.00 NS USD 54270.80 5.20 Long EC CORP US N 1 N N N Philip Morris International Inc. HL3H1H2BGXWVG3BSWR90 Philip Morris International, Inc. 718172109 514.00 NS USD 47586.12 4.56 Long EC CORP US N 1 N N N Raytheon Technologies Corp. I07WOS4YJ0N7YRFE7309 Raytheon Technologies Corp. 75513E101 580.00 NS USD 41742.60 4.00 Long EC CORP US N 1 N N N Stryker Corporation 5493002F0SC4JTBU5137 Stryker Corporation 863667101 170.00 NS USD 46455.90 4.45 Long EC CORP US N 1 N N N The Hershey Co. 21X2CX66SU2BR6QTAD08 The Hershey Co. 427866108 213.00 NS USD 42617.04 4.09 Long EC CORP US N 1 N N N The Southern Co. 549300FC3G3YU2FBZD92 The Southern Co. 842587107 809.00 NS USD 52358.48 5.02 Long EC CORP US N 1 N N N Veeva Systems Inc. 549300YZEXPDB92M2F02 Veeva Systems, Inc. Class A 922475108 303.00 NS USD 61645.35 5.91 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc. 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals, Inc. 92532F100 174.00 NS USD 60506.76 5.80 Long EC CORP US N 1 N N N Xcel Energy, Inc. LGJNMI9GH8XIDG5RCM61 Xcel Energy, Inc. 98389B100 791.00 NS USD 45261.02 4.34 Long EC CORP US N 1 N N N 2023-09-29 AmericaFirst Quantitative Funds /s/ Rick Gonsalves Rick Gonsalves Trustee and President XXXX NPORT-EX 2 americadefensivenportex923.htm Converted by EDGARwiz



Schedule of Investments

September 30, 2023 (unaudited)

AmericaFirst Defensive Growth Fund














Shares or Principal



Security Description

 

 

Amount ($)

 

Fair Value ($)(1)

 






Common Stocks - 91.72%



Aerospace & Defense -  3.99%






Raytheon Technologies Corp.

580


41,743









Biotechnology - 14.88%







Biogen, Inc.   (2)




630


47,212

Gilead Sciences, Inc.




185


47,547

Vertex Pharmaceuticals, Inc. (2)



174


60,507
















155,266









Consumer Staples Distribution -   2.70%






Costco Wholesale Corp.




50


28,248









Electric Services - 9.36%







The Southern Co.




809


52,358

Xcel Energy, Inc.




791


45,261
















97,619









Food Products - 17.80%







Archer-Daniels Midland Co.



633


47,741

General Mills, Inc.




641


41,018

Mondelez International, Inc. Class A



782


54,271

The Hershey Co.




213


42,617
















185,647









Health Care Equipment and Supplies - 13.37%



 



Abbott Laboratories




499


48,328

Medtronic Plc. Ordinary Shares



570


44,665

Stryker Corporation




170


46,456
















139,449









Health Care Providers & Services - 6.05%






McKesson Corp.




145


63,053









Health Care Technology - 5.91%






Veeva Systems, Inc. Class A (2)



303


61,645









Pharmaceuticals - 13.10%






Eli Lilly & Co.




159


85,404

Johnson & Johnson




329


51,242
















136,646









Tobacco - 4.56%







Philip Morris International, Inc.



514


47,586









Total Common Stock




(Cost $                950,852)


956,902









Money Market Registered Investment Companies - 6.88%





Federated Hermes Institutional Prime Obligations Fund - Institutional Class, 5.43% (4)

71,747


71,747





Total Money Market Registered Investment Companies

(Cost $             1,022,599)


71,747





Total Investments - 98.64%

(Cost $             1,022,599)


1,028,649





Other Assets Less Liabilities - 1.36%



14,230





Total Net Assets - 100.00%



1,042,879





















(1)  Statement on Financial Accounting Standard No. 157 "Fair Value Measurements" - Various inputs are used in determining the value of the Fund's investments.

       These inputs are summarized in the three broad levels listed below.

         Level 1 - quoted prices in active markets for identical securities

         Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

         Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments)


       The following is a summary of the inputs used as of September 30, 2023 in valuing the Fund's assets carried at fair value:

















 

 

 

 

 

Investments in

 

Other Financial

Valuation Inputs

 

 

 

Securities

 

Instruments (3)

Level 1 - Quoted Prices

 

 

$

1,028,649

$

-

Level 2 - Other Significant Observable Inputs

 

 

 

 

-

Level 3 - Significant Unobservable Inputs

 

 

-

 

-

Total

 

 

 

$

1,028,649

$

0









       The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term

       debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment

       Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active

       market, such securities are reflected as Level 2.









(2)   Represents non-income producing securities.

(4)  Investment in affiliate. The yield shown represents the 7-day yield in effect at September 30, 2023.